RE:Paladin Labs' Revenue Guidance (2007-2012)Note: If i recall over Paladin's 19 years, there were at least two periods where growth stalled and it took a year to regain the momentum.
Now, they have a lot more cash and cash inflow frow which to attempt to maintain growth. The first 8 years for GUD have been very impressive.
Bigger growth than I ever saw could come in the 2025-2028 period - organically (my guess only). This could also lead to geographic spread into Israel and back to Sub-saharan South Africa (like they did with Pharmaplan and then Litha in a very cool two-step chess move.
Then, add the cash spend to buy other things. I would bet they are keeping a close eye on two other geographies ... East Europe and Australia/NZ.
The details don't really matter - because I trust the ROW build process. It's very hard, it's impossible for most companies to do (shareholders won't wait) and it requires for control to be in the hands of a few select people, those who aren't going to panic through ROW build.
Therefore ... it is going exactly as expected. The only important part right now is to ensure the company stays in the hands of those who want to make sure ROW happens.
Trust the process ... you know why? Cuz we can't do anything about it. You're either in (on trust) or you're out on frustration. There's really no in between.